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Improved outcomes in the recent management of
secondary aortoenteric fistula
Paul A. Armstrong, DO, Martin R. Back, MD, Jeffrey S. Wilson, MD, Murray L. Shames, MD,
Brad L. Johnson, MD, and Dennis F. Bandyk, MD, Tampa, Fla
Objective: We reviewed the presentation, management, and late events in a recent experience with aortic graft-enteric
communications (secondary aortoenteric fistula) to identify variables associated with poor outcomes.
Methods: Since 1991, 29 patients (19 men, 10 women; mean age, 70) presented with a secondary aortoenteric fistula. The
duration from aortic graft implantation to aortoenteric fistula development ranged from 8months to 180months (mean,
47months). Presenting symptoms included gastrointestinal bleeding (n 25), sepsis and retroperitoneal abscess (n 3),
and ruptured para-anastomotic aneurysm (n  1). One third (10/29) of patients were hypotensive at presentation.
Repair was accomplished by graft excision with axillobifemoral bypass (17 simultaneous, 8 staged), graft excision with in
situ deep vein replacement (n  2), or graft excision with rifampin-treated prosthetic replacement (n  2). Mean
follow-up was 51 months, and the incidence of late events was reported by life table methods.
Results: The operative (<30-day) mortality rate was 21%, with shock at presentation (P< .01), the need for preoperative
transfusion (P < .01), and use of suprarenal aortic clamping during aortoenteric fistula repair (P  .03) associated with
lethal outcome. Cumulative mortality related to aortoenteric fistula management was only 24% within an overall 5-year
survival rate of 61%. Freedom from recurrent infection or amputation was 86% and 88% at 5 years, respectively, and
assisted graft patency was 79%. Presence of staphylococcal species in 22% of patients and occasional operative findings of
adjacent perigraft “biofilm” suggests that underlying indolent graft infection may contribute to the development of
aortoenteric fistula in some cases.
Conclusion:Outcomes associated with aortoenteric fistula repair were surprisingly favorable in the absence of preoperative
hemodynamic instability. ( J Vasc Surg 2005;42:660-6.)Thankfully uncommon, direct communication with
the gastrointestinal (GI) tract remains the most dreaded of
aortic graft complications. Since the introduction of pros-
thetic graft materials, cases of secondary aortoenteric fistula
(AEF) have far outnumbered primary AEFs, with the classic
description of AEF developing between the proximal aortic
graft and the fourth portion of the duodenum.Meaningful,
directed analysis of secondary AEFs has been hampered by
their infrequent occurrence (1%) after open aortic recon-
struction and because AEFs account for a small fraction
(20% to 25%) of the possible presentations of aortic graft
infections described in most series.1-3
Aortic graft infections and AEFs tend to affect a dispro-
portionate number of grafts placed for ruptured abdominal
aortic aneurysms or repairs complicated by hematoma,
thrombosis, or wound infection. Although the exact patho-
genesis remains speculative, mechanical erosion of pros-
thetic material into adjacent bowel may be facilitated by a
lack of interposed retroperitoneal tissue or excessive pulsa-
tion of redundantly placed grafts. Alternatively, we believe
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660that an indolent underlying graft infection (ie, low-grade,
Staphylococcus epidermidis “biofilm” infection4) may pro-
mote inflammatory adherence and erosion of the adjacent
bowel to the perigraft abscess wall in some cases, such as can
occur with other retroperitoneal infectious processes (eg,
pancreatic pseudocysts, diverticular abscesses).
Because of the extremely high morbidity associated
with simultaneous complete graft excision and extra-
anatomic bypass (EAB) revascularization of the lower
extremities, alternative approaches have been suggested,
including staged procedures,5 single-step in situ graft re-
placement,3,6 and less-invasive endograft exclusion.7,8 We
also speculate that poor early outcomes may result from
delays in recognition, diagnosis, and definitive operative
treatment. From a recent, relatively large experience with
secondary AEF cases, we have sought to identify factors
associated with adverse early and late outcomes and offer
novel observations regarding the pathogenesis of graft-
enteric communications.
METHODS
Study design. Of 131 cases of prosthetic aortic graft
infection entered in our vascular surgical registry over the
last 13 years (1991 to 2004), we identified 29 patients
(22%) treated for a secondary AEF at our primary univer-
sity-affiliated hospitals. Medical records at our affiliated
institutions were reviewed with respect to details of initial
aortic reconstructions, clinical presentation of the AEF,
diagnostic modalities, surgical and adjunctive perioperative
management, microbiologic results, early (30-day) ad-
verse events, subsequent episodes of bypass failure by
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mortality. The influence of various patient-related and peri-
operative factors on early mortality were analyzed by 2
analysis (categoric variables) or t tests (continuous vari-
ables).
All patients with axillobifemoral (EAB) grafts were
followed postoperatively at 6-month intervals in a duplex
surveillance protocol. Primary graft patency was defined as
the interval from initial bypass construction during defini-
tive AEF management until development of stenosis,
thrombosis, or recurrent graft infection requiring revision
or segmental replacement. Secondary or assisted patency
was defined until thrombosis or recurrent infection of a
bypass component necessitated graft abandonment or con-
struction of a new inflow bypass.
Long-term primary and secondary bypass patency,
avoidance of limb loss or recurrent graft infection, and
survival were determined by Kaplan-Meier life table meth-
ods. Late survival was confirmed for all patients using the
Social Security Death Index (www.rootsweb.com). The
mean follow-up was 51 10 months after AEF operations,
with only four patients (86% complete follow-up) lacking
data for late events beyond known follow-up intervals of 18
to 51 months.
Presentation. The AEF group, 19 men and 10
women, had a mean age of 70 years (range, 58 to 80 years).
The initial indication for aortic reconstruction was an an-
eurysm in 21 patients (72%) and aortoiliac occlusive disease
in eight (28%). An aortobifemoral bypass configuration had
been most commonly used (n 19), with aortobiiliac (n
7) and aortic tube grafts (n 3) less frequently present. All
repairs had been done with polyester grafts (n 27) except
two cases with polytetrafluoroethylene (PTFE) conduits.
Six of the initial procedures for aneurysms were done
emergently for rupture, and the remainder of the aortic
reconstructions were electively performed. Five patients in
the elective group had graft-related complications after
their original surgery. Two of these patients required addi-
tional operations for aortofemoral graft limb thrombosis.
Three patients needed reoperative procedures for groin
wound complications, with one of these requiring partial
graft limb resection for infection and placement of a cross-
femoral bypass.
The interval between the initial aortic surgery and
development of clinical symptoms related to AEF was 8 to
180 months (average, 47 months). In two patients, the
initial aortic reconstructions were done in our university-
affiliated hospitals; and in the other 27 patients, the original
aortic grafts were placed at outside hospitals. Detailed
records related to these latter patients and initial graft
implants were only sporadically available from outside hos-
pitals.
Of the 25 patients presenting with GI bleeding, 18
(72%) experienced an initial “herald” bleed that prompted
admission at the community hospital, whereas seven indi-
viduals reported multiple recurrent bleeding episodes. GI
bleeding (melena or hematemesis) occurred over a mean
interval of 3 days (range, 4 hours to 12 months) beforepresentation at outside hospitals, however, indicating rela-
tive chronicity of symptoms in many patients. Other pre-
sentations included sepsis, abdominal pain, and retroperi-
toneal abscess in three patients (10%), and back pain with a
contained rupture of a proximal para-anastomotic aneu-
rysm in one case (4%).
The diagnosis of AEF was suspected before transfer in
only 18 of the 27 referred patients despite the performance
of multiple diagnostic tests at outside hospitals in most
patients. Endoscopic evaluation of bleeding was common,
with esophagogastroduodenoscopy (EGD) done in 25 pa-
tients and colonoscopy in 15 cases. Additional testing for
GI bleeding included arteriography (n  13) and contrast
GI studies (n  12). Radionuclide imaging studies (for
bleeding or infection) or magnetic resonance imaging were
used infrequently (n 3). All but three of 25 EGD studies
performed elsewhere failed to confirm the location of GI
bleeding or raise suspicion for AEF (ie, finding of fresh
blood in distal duodenum). EGD was repeated after trans-
fer in five patients with diligent inspection beyond the
proximal duodenum using a pediatric colonoscope. Abnor-
malities including fresh adherent mucosal clot (n  1) and
exposed aortic prosthetic graft (n  2) were detected in
three of the five repeat studies.
Abdominal/pelvic computerized tomography (CT)
scans were performed in 28 of the 29 patients, but nine
studies from outside facilities were deemed suboptimal on
our review and were repeated after transfer using both oral
and intravenous contrast enhancement and high-resolu-
tion, spiral, thin-slice (3 to 5 mm) image acquisition tech-
niques. Overall, 26 (93%) of 28 patients demonstrated CT
abnormalities consistent with the presence of AEF, ranging
from obvious direct communication between the duodenal
and perigraft space (contiguous gas bubble or oral contrast
distribution as seen in Fig 1) to more subtle loss of retro-
peritoneal soft tissue interposed between overlying bowel
and the proximal aortic graft.
Only three patients (10%) with clinical suspicion for
AEF thus required confirmatory transabdominal explora-
tion after nondiagnostic CT scans or other testing. Only a
single patient also manifested groin sepsis and diffuse aor-
tofemoral limb perigraft fluid on CT, whereas the remain-
ing aortobifemoral bypasses (n  18) with AEF demon-
strated sparing of the distal graft limbs of any inflammatory
or infectious changes.
One third of patients (10 of 29) presented with hypo-
tension in hypovolemic (n  7) or septic (n  3) shock.
Preoperative transfusion of packed red blood cells, ranging
from 1 to 12 units (mean, 5 units), was needed in 11
patients (38%), and vasopressor infusions were required in
two of the three sepsis cases before surgery.
Despite the high acuity of these presentations, only five
of these patients were emergently transferred (12 hours
of admission) from outside hospitals. The remainder of
transfers occurred after an interval of 1 to 18 days (mean, 5
days) spent at community hospitals for presumed diagnos-
tic evaluation, attempts at clinical stabilization, or both.
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otics that include coverage of enteric flora (vancomycin
plus third or fourth generation cephalosporin or aminogly-
coside or fluoroquinolone or antipseudomonal penicillin
with -lactamase inhibitor) were administered to all pa-
tients with a suspected AEF after transfer. Intraoperative
periaortic tissue and graft cultures and a Gram stain of
perigraft fluid were obtained in all patients. Specific tech-
niques aimed at recovery of S. epidermidis (ie, ultrasonica-
tion and trypticase soy broth culture) were not used in the
series. Parenteral antibiotic therapy was adjusted to sensi-
tivity results and continued for at least 4 weeks, with oral
agents continued for up to 3 months. One patient with
recurrent infection was kept on a suppressive dose of peni-
cillin (250 mg/day) indefinitely.
Definitive AEF management was accomplished by
complete prosthetic graft excision through a transabdomi-
Fig 1. (A) Contiguous gas bubble extending from duodenal
lumen into perigraft space of proximal aortic graft is seen in
noncontrast images of high-resolution computed tomography
(CT) scan. (B)Oral contrast administration reveals direct commu-
nication between duodenum and perigraft space of an end-side
proximal aortic graft reconstruction on CT scan. Adjacent native
aorta remains patent.nal approach in all but one case (left retroperitoneal). Atexploration, graft communication with the distal duode-
num/proximal jejunum was found in 27 patients and with
the ileum or transverse colon in one case each. Small-bowel
defects were repaired by layered transverse closure or hand-
sewn reanastomosis sometimes requiring extended proxi-
mal duodenal mobilization. Resection and proximal diver-
sion was required in the single case of sepsis and colonic
involvement. Enteral repairs were done early in the opera-
tion to avoid later handling of edematous bowel potentially
occurring after large volume resuscitations during aortic
graft excision. Bowel communication involved the proxi-
mal anastomosis in 20 patients (only 3 with anastomotic
aneurysm development, 1 ruptured) and only the graft
body or limb in nine cases.
In five cases, unincorporated prosthetic material with
adjacent biofilm fluid4 present over an extended length of the
graft body, limb, or both was encountered beyond the adher-
ent bowel. Biofilm infections were defined by presence of a
beige, odorless, slime, perigraft fluid having a Gram stain that
contained occasional white blood cells but no organisms and
cultures revealing S. epidermidis or S. aureus.
Extra-anatomic lower-limb revascularization (EAB)
was done by axillofemoral (8 mm supported PTFE) and
cross-femoral (6 mm for small, diseased femoral arteries
and 8-mm PTFE) bypass grafting through clean tissue
planes in 25 patients. In 10 cases, simultaneous repairs were
sequenced with EAB construction done first by using two
surgical teams to minimize operative time, followed by
single-team graft excision and bowel repair. Simultaneous
graft excision and bowel repair followed by EAB was ur-
gently required in seven hypotensive patients with GI
bleeding (n 4), uncontrolled sepsis (n 2), or a ruptured
para-anastomotic aneurysm (n  1). Staged EAB followed
by graft excision 2 to 4 days later (mean, 2.9 days) was
possible in eight patients remaining hemodynamically sta-
ble after transfer. Graft limbs were completely excised from
native femoral arteries and oversewn distally during EAB
construction or heparin was used in the days before the
graft excision when competitive flow was present between
the EAB and the existing aortic graft.
Two patients presenting with severe lower-limb isch-
emia and multilevel occlusive disease (one of these with a
diffuse aortofemoral graft limb infection extending to
the groin) were treated with single-stage graft excision,
in situ unilateral aortofemoral replacement with femoral-
to-popliteal (deep leg) vein, and additional lower-limb
bypasses. Two additional patients with pararenal aortic
aneurysmal degeneration above their infected infrarenal
graft required in situ replacement with rifampin-soaked
(30 mg/mL), gelatin-impregnated Dacron (DuPont,
Wilmington, Del) grafts and visceral artery branch (2 re-
nals, 1 superior mesenteric artery) (SMA) reimplantation.
Including these latter two patients, AEF management ne-
cessitated aortic cross-clamping at the suprarenal level in six
cases and supraceliac occlusion in one patient. The result-
ing durations of ischemia (renal, mesenteric, or both) were
22 to 45 minutes (mean, 31  8 minutes) during cross-
clamping, with or without visceral artery reimplantation.
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all prosthetic graft and anastomotic materials, aggressive
débridement of infected or inflamed perigraft tissues, and
two-layer polypropylene closure of infrarenal aortic stumps
when EAB was used. Pulsed mechanical irrigation of retro-
peritoneal beds with dilute Clorpactin (bleach) solution
(United-Guardian, Inc, Hauppauge, NY) and liberal pas-
sive irrigation with a solution of 1:1:1 Betadine (Purdue
Pharma, Stanford, Conn), hydrogen peroxide, and sterile
saline were used intraoperatively to reduce residual bacte-
rial contamination after graft excision and AEF repair. A
pedicle of omentum brought without tension along the left
paracolic gutter into the retroperitoneal bed was also used
to aid healing. Bowel repairs were assessed with an upper
GI contrast study before the resumption of oral intake.
RESULTS
Microbiology. Bacterial isolates from intraoperative
cultures encompassed only gram-negative species in 15
patients (52%), only gram-positive species in six (21%),
both gram-positive and negative species in six (21%), and
no growth in two patients (6%). Escherichia coli (52%) was
the most common gram-negative isolate, followed byKleb-
siella species (17%). Of the 42% of cases where gram-
positive species were recovered, S. epidermidis was present
in half (n  6). However, methicillin-resistant S. aureus
(MRSA) was found in only the patient with an AEF and
distal aortofemoral limb involvement (4% of all isolates).
Early adverse events. Operative (30 day) mortality
was 21% (6/29). Four patients died 24 hours of surgery
due to massive transfusion and consumptive coagulopathy
(n  2) or overwhelming septic shock (n  2). An addi-
tional two patients died from an extensive stroke (n 1) or
pneumonia (n 1) within several weeks of operation. One
patient with severe multilevel occlusive disease required
below-knee amputation (3% early limb loss) after the re-
peated failure of a concomitantly constructed distal bypass.
Three patients (10%) needed early revisions of groin
wounds (n  2) or the underlying EAB graft (n   1).
Univariate testing revealed several predictors of opera-
tive mortality (Table). Early death occurred in more than
half of patients presenting with hypovolemic or septic shock
(P .01), requiring preoperative transfusion (P .01), or
needing suprarenal or supraceliac aortic clamping during
AEF repair (P  .03). Some overlap of prognostic factors
existed, however, as four of six operative deaths were asso-
ciated with presence of preoperative shock, ongoing trans-
fusion, and need for suprarenal aortic clamping. No signif-
icant difference was noted in operative mortality between
staged EAB and graft excision procedures and simulta-
neous management (13% vs 24%, P  .4). There was a
trend towards higher mortality for AEF cases involving
gram-positive organisms compared with those who had
gram-negative isolates only (P  .06). Despite the clinical
severity of patient presentations in one third of cases, the
interval between the initial onset of symptoms related to
AEF and definitive surgical procedures after transfer did not
affect operative mortality (P  .7).Late outcomes. Of four late deaths occurring during
follow-up, only one was related to AEF treatment. This
patient developed recurrent infection and aortic stump
dehiscence and succumbed despite reoperations 16months
after graft excision and EAB. Causes of late death in the
remaining three patients were attributed to renal failure,
stroke, and pulmonary failure, respectively. Cumulative
mortality directly related to AEF management was 24%.
Overall 5-year survival by life table methods was a respect-
able 61%, especially after the initial 21% early perioperative
mortality (Fig 2). In addition to the one case of aortic
stump sepsis, two other patients developed late recurrent
infection involving the EAB and required segmental re-
placement of axillofemoral-femoral bypasses. Freedom






death 70  8 yrs .9
survivors 70  7 yrs
Sex
men 26 (5/19) .3
women 10 (1/10)
Indication original aortic reconstruction
Abdominal aortic aneurysm 29 (6/21) .18
aortoiliac occlusive disease 0 (0/10)
Original aortic reconstruction
aortoiliac/tube graft 30 (3/10) .4
aortofemoral bypass 16 (3/19)
Duration implant to AEF
death 54  16 mo .8
survivors 47  13 mo
AEF presentation
sepsis/ruptured pseudoaneurysm 50 (2/4) .25
Gastrointestinal bleed 16 (4/25)
AEF location
proximal anastomosis 25 (5/20) .35
graft body/limb only 11 (1/9)
Duration AEF symptoms to treatment
death 5  4 days .15
survivors 8  5 days
AEF operative treatment
simultaneous procedure 24 (5/21) .4
staged EAB/graft excision 13 (1/8)
Graft bacteriology
gram  / mixed flora / no growth 36 (5/14) .06
gram – only 7 (1/15)
Presenting hemodynamic stability
shock / hypotension 60 (6/10) .01*
stable blood pressure 0 (0/19)
Presenting anemia
pre-op transfusion PRBCs 55 (6/11) .01*
no transfusion 0 (0/18)
Aortic clamp level for AEF repair
suprarenal/supraceliac 57 (4/7) .03*
infrarenal 9 (2/22)
AEF, Aortoenteric fistula; EAB, extra-anatomic bypass; PRBCs, packed red
blood cells.
*Significant difference in mortality between groups.from recurrent infection was 86% at 5 years (Fig 3).
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ated with recurrent infection and one resulting in late
amputation contributed to by unreconstructable infrain-
guinal disease. Freedom from amputation was 88% at 5
years, with only two limbs cumulatively lost (Fig 4). Of
perioperative survivors, cumulative freedom from death,
recurrent infection, amputation, or EAB graft loss was 69%,
with one third of these events being late deaths unrelated to
AEF management. Primary, stenosis-free patency of axil-
lofemoral-femoral (EAB) grafts was 64% at 5 years by life
table estimates (Fig 5). Duplex surveillance of EAB allowed
identification and salvage of three failing grafts and resulted
in a 5-year assisted patency rate of 79%.
DISCUSSION
Secondary AEF remains one of the most challenging
vascular pathologic entities to treat. However, early (21%)
and cumulative late (24%) mortality related to AEF man-
agement and long-term survival (61% at 5 years) were
surprisingly favorable in our series and approach the recent
results of others encompassing predominantly aortic graft
Fig 2. Late survival after aortoenteric fistula repair was 61% at 5
years by life table methods, with infrequent deaths in patients
surviving initial management (21% operative mortality). SE 10%
at all time points.
Fig 3. Recurrent infections of aortic stump (n  1) or extra-
anatomic bypass (n  2) during long-term follow-up were infre-
quent. SE 10% for life table estimates.infections without enteric involvement.9,10 Operative mor-tality rates have ranged up to 40% in some older AEF series.
Factors associated with early death in our series included
shock at presentation, preoperative blood transfusion for
anemia, and need for aortic clamp placement above the
renal arteries during AEF repair. Conversely, no operative
deaths occurred in the absence of hemodynamic instability
at presentation (n  19). Predictive factors were similar to
those found by Kieffer et al,3 which included presenting
shock, emergency operations, and postoperative complica-
tions predicting early death.
Some delay in AEF management was observed in our
series. Only five of 10 patients who presented initially with
shock were urgently transferred to us for definitive care; an
average of 5 days were spent at outside hospitals, with one
third of patients not having AEF considered as a diagnosis
at transfer, and despite one quarter of patients with GI
hemorrhage had experienced multiple recurrent bleeds
Fig 4. After aortoenteric fistula repair, there was an 88% freedom
from limb loss at 5 years. SE 10% for life-table estimates.
Fig 5. The rate of 5-year primary, stenosis-free patency of axillo-
bifemoral grafts after aortoenteric fistula repair was 64%. There was
an improvement of assisted patency to 79% at 5-years using long-
term duplex surveillance of extra-anatomic bypass. SE 10% at all
intervals.prior to referral. We could not demonstrate a direct link
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agement (duration between symptom onset, hospital ad-
mission, transfer interval, and eventual definitive surgical
intervention) and operative mortality, however.
Use of high quality CT scanning with oral and intrave-
nous contrast had 93% sensitivity in detecting AEF. In
patients with more subtle CT abnormalities (eg, loss of
retroperitoneal fat between the aortic graft and adjacent
duodenum), diligent endoscopic inspection of the proxi-
mal bowel with a pediatric colonoscope may reveal AEF in
a many cases (3/5 of our patients), and a low threshold for
operative exploration must be maintained. Because the
combination of CT scanning and diligent upper endoscopy
possessed high diagnostic accuracy for AEF, delays in diag-
nosis observed in our series likely resulted from the early
failure at outside hospitals to consider the presence of AEF.
A history of aortic reconstruction, the presence of a long
abdominal scar, and recent GI bleeding should raise suspi-
cion for AEF in emergency, primary care, and consulting
physicians and prompt expedient transfer to a tertiary facil-
ity capable of definitive AEF management.
Several alternative approaches to simultaneous enteric
repair, complete aortic graft excision, and axillobifemoral
bypass have evolved to potentially lessen operative time, the
magnitude of perceived “physiologic stress,” and high early
mortality. The University of California, San Francisco
group5,11 has shown reduced operative mortality with a
staged approach of initial EAB followed 1 to 3 days later by
AEF repair and graft excision.
Although we have also observed a trend towards lower
mortality with staged procedures, we believe that simulta-
neous initial EAB done by a two-team approach can be
completed in 60 to 90minutes and subsequent single-team
aortic graft excision (without repositioning or re-prepping)
can be safely accomplished in the absence of preoperative
hemodynamic instability. This operative sequence was used
without lethal outcome in eight of our patients. Initial
urgent graft excision and bowel repair, followed by re-
prepping and EAB construction, remains necessary in pa-
tients with active hemorrhage or septic shock.
Despite concern over the long-term function of the
axillofemoral bypass after the excision of infected aortic
grafts,12 our favorable late results were similar to the low
incidence of EAB failure, recurrent infection, and limb loss
seen by Seeger9 and Yeager.10 Late disruption of the ligated
aortic stump from recurrent infection was also more un-
common in our and other recent experiences9,10 than that
reported in earlier series.13
In situ replacement techniques have also been used for
AEF management. Kieffer et al3 recently described fresh
and cryopreserved allograft replacement of infected in-
frarenal aortic grafts, including nearly one third of pa-
tients (n  54) presenting with secondary AEF. How-
ever, four of these AEF patients (7%) died of residual
infection and allograft rupture within 1 to 2 months of
replacement procedures.
During long-term follow-up of all infected aortic grafts
treated by allograft replacement, there were three (2%) latedeaths from rupture, at least two (1%) recurrent infections,
only one (1%) major amputation, and an overall 55%
5-year patient survival. Freedom from late adverse events
(occlusive lesions or dilatation/aneurysm formation) at 5
years after replacement was 89% for aortic portions of the
allograft and 66% for iliofemoral limbs. This latter failure
rate of distal allograft segments does not differ from axil-
lofemoral bypass patency rates, suggesting nearly equiva-
lent long-term lower-limb revascularization results using
either graft excision/EAB or in situ allograft replacement
techniques.
In situ replacement of AEF with a prosthetic graft has
been used sporadically.6 Rifampin-treated Dacron conduit
has been successful in replacement of low-grade biofilm
infections involving aortoiliofemoral grafts.14,15 However,
recurrent or residual infections observed in the presence of
MRSA or rifampin-resistant S. epidermidis cast doubt on
the ability of an in situ prosthetic replacement to effectively
withstand the invasive gram-negative bacteria encountered
with AEF.
A pararenal aneurysm associated with an infrarenal
graft-enteric fistula may occasionally necessitate in situ
prosthetic replacement, as seen in two of our patients. The
construction of an in situ, neoaortoiliac system from deep
leg vein16,17 is generally not recommended for treatment of
secondary AEF. Direct invasion of the transposed autolo-
gous tissue by virulent gram-negative bacteria (eg, Pseudo-
monas species) and potential for conduit disruption exists
for neoaortoiliac system replacement of AEF. However,
neoaortoiliac system construction could be considered in
the occasional patient with an underlying biofilm infection,
a limited graft body/limb-to-enteric erosion, significant leg
ischemia, and the potential need for multilevel bypass and
hemodynamic stability. Endovascular graft exclusions as a
less-invasive in situ treatment of secondary AEFs have also
failed because of residual infection and may represent only
a bridge to conventional open repair in hemodynamically
unstable patients with active hemorrhage.7,8
Based on the microbiologic results and operative find-
ings, we believe that not all AEFs are solely related to
pulsatile mechanical forces causing prosthetic erosion into
adjacent bowel. The local inflammatory response associated
with an indolent underlying biofilm infection may promote
adherence of adjacent bowel to facilitate eventual erosion
and enteric luminal communication with the infected pros-
thetic graft surface in some cases. This concept is supported
by the fact that Staphylococcal species were identified by
culture results in 22% of our AEF cases, and in five patients,
biofilm fluid was found on unincorporated graft surfaces
beyond regions of direct small-bowel communication and
bilious/enteric staining of the aortic prosthesis.
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